Abstract
Purpose
This study is focused on monitoring process parameters and quality attributes of aluminum phosphate (AlPO4) using multiple in-line probes incorporated into an industrial-scale adjuvant suspension manufacturing unit.
Methods
The manufacturing of aluminum adjuvant suspension was monitored at manufacturing scale using conductivity, turbidity, infrared, and particle sizing and count probes to follow the continuous evolution of particle formation and size distribution, and the reaction kinetics during the synthesis of AlPO4.
Results
The data showed that AlPO4 forms large particles at the early stages of mixing, followed by a decrease in size and then stabilization towards the later stages of mixing and pH adjustment. The results provided a complementary view of process events and assisted in optimizing several parameters, e.g., flow rate of reactants AlCl3 and Na3PO4 solutions, mixing rate, pH, and conductivity of AlPO4, as well as adjuvant quality attribute such as particle size, thus streamlining and shortening the process development stage.
Conclusion
The results of this study showed the usefulness of the in-line probes to automate continuous assessment of AlPO4 batch-to-batch consistency during in-house adjuvant production at the industrial scale.
Graphical Abstract
Similar content being viewed by others
References
Hem SL, Hogenesh H. Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev Vaccines. 2007;6:685–98.
Kalbfleisch K, Deshmukh S, Mei C, Ore M, Williams W, Durowoju I, et al. Identity, Structure and Compositional Analysis of Aluminum Phosphate Adsorbed Pediatric Quadrivalent and Pentavalent Vaccines. Comput Struct Biotechnol J. 2019;17:14–20. Available from: https://www.sciencedirect.com/science/article/pii/S2001037018301156. Accessed 13 Dec 2023.
Process Analytical Technology. European Pharmacopeia 10.4, Chapter 5.25. 04/2021.
FDA Guidance for Industry. PAT—A Framework for Innovative Pharmaceutical Development, Manufacturing, and Quality Assurance. 2004.
Mei C, Deshmukh S, Cronin J, Cong S, Chapman D, Lazaris N, Sampaleanu L, Schacht U, Drolet-Vives K, Ore M, Morin S, Carpick B, Balmer M, Kirkitadze M. Aluminum Phosphate Vaccine Adjuvant: Analysis of Composition and Size Using Off-Line and In-Line Tools. Comput Struct Biotechnol J. 2019;17:1184–94. https://doi.org/10.1016/j.csbj.2019.08.003.
Razani M, Gerzon G, Patt M, Dhaliwal S, Hunter HN, Sheng Y, Kirkitadze M. Near Infrared Spectroscopy - A Real-Time Method to Measure Aluminum Content and Protein Concentration in Adsorbed Vaccines. J Vaccines Immunol Immunopathol. 2022;7:167. https://doi.org/10.29011/2575-789X.000167.
Carmona P, Rodriguez ML. Hydrogen bonding between phosphate and amino acid side chains. J Mol Struct. 1986;143:365–8. https://doi.org/10.1016/0022-2860(86)85278-4.
General notices. European Pharmacopeia 10.0, p.5371–5373.
Synchronised Total Quality (synTQ) PAT knowledge manager. https://www.syntq.com. Accessed 13 Dec 2023.
Redman T, O’Grady D, Improve Products and Processes with In-line Particle Analysis, AIChE 2017; August:47–55. https://www.aiche.org/resources/publications/cep/2017/august/improve-products-and-processes-inline-particle-analysis.
Aluminum Compounds Used as Adjuvants in Vaccines. Shirodkar S, Hutchinson RL, Perry DL, White JL, Hem SL. Pharma Res. 1990;7:1282-1288. https://doi.org/10.1023/a:1015994006859.
Yan S, Gu W, Xu ZP. Re-considering how particle size and other properties of antigen-adjuvant complexes impact on the immune responses. J Colloid Interface Sci. 2013;395:1–10. https://doi.org/10.1016/j.jcis.2012.11.061.
Haer M, Payne J, Strahlendorf K, Jung R, Xiao E, Kowal P, Gemmiti G, Cronin J, Gable T, Park-Lee K, Drolet-Vives K, Balmer M, Kirkitadze M. PAT Solutions to Monitor Adsorption of Tetanus Toxoid with Aluminum Adjuvants. J Pharm Biomed Anal. 2021;198: 114013. https://doi.org/10.1016/j.jpba.2021.114013.
Acknowledgements
Authors would like to thank Kira Li, Yu Chen Lin, Wayne Williams, and Madeline Patt for their support with LD measurements over the course of the study, Olivier Level and Pascale Gonnet for discussions, and Jean-Sébastien Bolduc (Sanofi) for editorial assistance.
Funding
This study was funded by Sanofi.
Author information
Authors and Affiliations
Contributions
All authors substantially contributed to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work, and provided final approval of the version to be published. P.K., G.F., and M.K. contributed to drafting the work and revising it critically for important intellectual content.
Corresponding author
Ethics declarations
Conflicts of Interest
Przemyslaw Kowal, Ginny Fung, Gabriel Gemmiti, Liliana Sampaleanu, and Marina Kirkitadze are employees of Sanofi and may hold shares and/or stock options in the company. James T. Cronin is an employee of Mettler Toledo and has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kowal, P., Fung, G., Gemmiti, G. et al. Application of PAT Probes in Aluminum Phosphate Adjuvant Manufacturing. Pharm Res 41, 375–385 (2024). https://doi.org/10.1007/s11095-023-03642-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-023-03642-6